Clinical Trial Update: Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trastuzumab with chemotherapy in locally recurrent or metastatic urinary tract cancers has completed, including transitional c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Squamous Cell Carcinoma of the Bladder
• Transitional Cell Carcinoma of the Bladder
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer | Phase 2 | Status: COMPLETED